Position in CLDX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,905,673
+$1,178,293 QoQ
Shares Held
104,963
+22.1% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 252 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 24%
Shared 0%
None 76%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. CLDX ranks #65 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in CLDX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,905,673 | 104,963 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,727,380 | 85,983 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,370,090 | 87,264 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,668,671 | 103,157 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,169,289 | 106,599 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,783,527 | 98,266 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $2,323,298 | 91,939 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $3,147,100 | 92,589 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,570,724 | 96,480 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $4,135,304 | 98,530 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,015,032 | 76,022 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,110,068 | 76,674 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,495,653 | 73,553 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,659,785 | 73,924 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,204,939 | 71,908 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,978,241 | 70,375 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,751,267 | 64,958 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,778,579 | 52,219 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,925,160 | 49,823 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,659,817 | 49,265 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,365,522 | 40,835 | Shares | Sole | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||